Phio Pharmaceuticals Corp. Made Big Gain
Phio Pharmaceuticals Corp. (PHIO:NASDAQ) jumped higher at $5.05, representing a gain of 34.3%. On Thu, May 18, 2023, PHIO:NASDAQ touched a New 2-Week High of $5.05. The stock got featured on our News Catalysts scanner on Thu, May 18, 2023 at 01:04 PM in the 'BIOTECH' category. From Thu, May 04, 2023, the stock recorded 50.00% Up Days and 27.27% Green Days
The stock spiked on Thu, May 18, 2023 at $6.85 with a volume of 16M+.
About Phio Pharmaceuticals Corp. (PHIO:NASDAQ)
RXi Pharmaceuticals Corp is principally engaged in developing therapeutics based on its proprietary self-delivering RNAi platform and Samcyprone, a topical immunomodulator, which addresses significant unmet medical needs.
Top 10 Gainers:
- Enveric Biosciences Inc. (ENVB:NASDAQ), 136.96%
- AVROBIO, Inc. (AVRO:NASDAQ), 45.33%
- Wang & Lee Group Inc. (WLGS:NASDAQ), 44.7%
- Sonder Holdings Inc. (SOND:NASDAQ), 41.37%
- Eltek Ltd. (ELTK:NASDAQ), 36.96%
- GSI Technology, Inc. (GSIT:NASDAQ), 35.78%
- Phio Pharmaceuticals Corp. (PHIO:NASDAQ), 34.31%
- Cue Health Inc. (HLTH:NASDAQ), 29.72%
- Stryve Foods Inc. (SNAX:NASDAQ), 29.5%
- Urstadt Biddle Properties Inc. (UBP:NYSE), 28.44%